The main advantages of EpiVacCorona, the COVID-19 vaccine developed by the State Research Center of Virology and Biotechnology Vector in the Russian city of Novosibirsk, are its effectiveness, safety and simplicity of production, the center's Director-General Rinat Maksyutov said on Monday.
"The expected advantage of this vaccine compared to other...
Russian scientists made global headlines in August when they unveiled Sputnik V, the first Covid-19 vaccine to be approved anywhere in the world. But as its roll-out nears, health officials face growing vaccine skepticism, RT reported.
New polling from Moscow's Levada Center this week shows that as many as six...
Russia’s coronavirus case tally grew by 22,572 in the past day to 1,925,825, the anti-coronavirus crisis center told reporters on Sunday, as reported by TASS. A day earlier, 22,702 COVID-19 cases were reported, a new high during the pandemic.
The lowest growth rates in the past day were recorded in...
The vaccine developed by AstraZeneca in collaboration with Oxford University demonstrated 62% efficacy - a far cry from the 90% and over shown in the trials of two US and one Russian vaccine that were presented earlier, Sputnik reports.
The developers of Russia’s Sputnik V vaccine have suggested that AstraZeneca...
Russia’s coronavirus cases grew by 26,190 in the past day and the total case tally reached 2,541,199, the anti-coronavirus crisis center told reporters on Wednesday, TASS reported.
In the past day, the growth rate did not exceed 1%.
The lowest growth rates were registered in the Chukotka Autonomous Region (0.5%), the...
The number of coronavirus infections in Russia went up by record-high 29,350 in the past 24 hours, bringing the total to 2,877,727, the national anti-coronavirus crisis center told reporters Monday.
According to the crisis center, the increase does not exceed 1%, TASS reports.
The slowest infection increases in the past 24...
The Russian coronavirus vaccine Sputnik V was thoroughly tested, within a mechanism that was later picked up by major producers of foreign vaccines, Alexander Gintsburg, the head of the Gamaleya Institute of Epidemiology and Microbiology, told Sputnik on Tuesday.
Sputnik V was the world's first coronavirus vaccine officially registered for...
The head of Russia's Gamaleya research institute, which developed the Sputnik V vaccine, explained to Sputnik on Friday that those who had already had the coronavirus should be vaccinated anyway, two of three months after recovering, Sputnik reports.
Alexander Gintsburg stressed that he does not agree with the health ministry's...
Russia confirmed 17,741 coronavirus cases in the past day, a record low since October 29, the anti-coronavirus crisis center reported, TASS reports.
The total coronavirus caseload hit 3,774,672. The average growth rate reached 0.47%.
The lowest growth rates in the past day were registered in the Tuva Republic (0.07%), the Altai...
About 2,200,000 people in Russia have received the first dose of the Sputnik V coronavirus vaccine, Deputy Research Director at the Gamaleya Research Institute of Epidemiology and Microbiology Dmitry Logunov said at a round table hosted by the Moscow City Council on Wednesday.
"In total, about 2.2 mn people have...
